Achalasia cardia: A case report in young female

Deepak Subedi1, Binod Raj Parajuli2, Neha Bista3

  • 1Nepalese Army Institute of Health Sciences College of Medicine Kathmandu Nepal.

Clinical Case Reports
|August 6, 2024
PubMed

Insights

Early diagnosis of achalasia in young adults is crucial to prevent worsening symptoms and misdiagnosis as GERD. Prompt identification and treatment significantly improve patient outcomes and quality of life.

Area of Science:

  • Gastroenterology
  • Esophageal Motility Disorders

Background:

  • Achalasia is caused by the loss of inhibitory neurons in the esophagus, leading to absent peristalsis and failure of the lower esophageal sphincter (LES) to relax.
  • Its etiology is multifactorial, involving potential infections, autoimmune responses, and genetic factors, affecting males and females equally.

Observation:

  • A 22-year-old female presented with persistent dysphagia and regurgitation, initially misdiagnosed as gastroesophageal reflux disease (GERD).
  • Diagnostic evaluations including barium esophagogram and manometry confirmed Type II Achalasia Cardia.
  • Pneumatic balloon dilatation (PBD) resulted in significant symptom relief.

Findings:

  • Achalasia diagnosis in young adults is challenging due to varied presentations mimicking other esophageal disorders like GERD.
  • Key diagnostic tools include barium esophagogram (bird's beak sign) and manometry (absent peristalsis).
  • Upper gastrointestinal endoscopy is essential to exclude malignancy.

Implications:

  • Considering achalasia in young adults with unexplained dysphagia is vital, especially when GERD treatments are ineffective.
  • Timely diagnosis and management, including PBD, laparoscopic Heller myotomy, or POEM, improve clinical outcomes.
  • Regular endoscopic surveillance is recommended due to the risk of esophageal carcinoma transformation.

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
58
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
133
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
75
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
54
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K